Produkty 116-59-6

CAS 116-59-6 występuje w naszej ofercie pod nazwami: 20Beta-Dihydrocortisone, >95% (HPLC), 20betha-Dihydrocortisone, >95% (HPLC). Oferty producentów: TRC. Dostępne opakowania: 500mg, 50mg.

20Beta-Dihydrocortisone, >95% (HPLC)
TRC
  • opakowanie: 500mg
  • Warianty: 1
Zobacz produkt
20betha-Dihydrocortisone, >95% (HPLC)
TRC
  • opakowanie: 50mg
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(8S,9S,10R,13S,14S,17R)-17-[(1R)-1,2-dihydroxyethyl]-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,11-dione (CAS 116-59-6) to związek chemiczny o wzorze sumarycznym C21H30O5 i masie molowej 362.5 g/mol. Nazwa systematyczna IUPAC: (8S,9S,10R,13S,14S,17R)-17-[(1R)-1,2-dihydroxyethyl]-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,11-dione. InChIKey: XBIDABJJGYNJTK-GNIMZFFESA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H30O5
Masa molowa362.5 g/mol
Nazwa IUPAC(8S,9S,10R,13S,14S,17R)-17-[(1R)-1,2-dihydroxyethyl]-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,11-dione
InChIKeyXBIDABJJGYNJTK-GNIMZFFESA-N
SMILESC[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CC[C@@]4([C@@H](CO)O)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 20beta-Dihydrocortisone, 20beta-Hydroxycortisone, (20R)-17,20,21-Trihydroxypregn-4-ene-3,11-dione, 20b-Dihydrocortisone, 4-Pregnene-17alpha,20beta,21-triol-3,11-dione, 17,20,21-Trihydroxypregn-4-ene-3,11-dione, (20R)-, Pregn-4-en-3,11-dione, 17,20,21-trihydroxy-, (20R)-, 4-Pregnene-17alpha,20beta,21-triol-3,11-dione [MI], 20?-Dihydrocortisone, 20betha-Dihydrocortisone
Izomery (ten sam wzór sumaryczny)
6,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O5
(8S,9S,10R,11S,13R,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-13-(hydroxymethyl)-10-methyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H30O5
3,4-dihydroxy-2-(2-methylbutanoyl)-5-(3-methylbut-2-enyl)-4-(4-methylpent-3-enoyl)cyclopent-2-en-1-one C21H30O5
(8S,10R,11S,13S)-9,11,12,12-tetradeuterio-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one C21H30O5
2-[[(8R,9S,10S,13S,14S,17S)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-10-yl]methoxy]acetic acid C21H30O5
2-hydroxy-2-[(8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]acetic acid C21H30O5
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O5
(8S,9S,10R,11S,13S,14S,17R)-17-[(1R)-1,2-dihydroxyethyl]-11,17-dihydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C21H30O5
3,5,6-trihydroxy-2-(2-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one C21H30O5
(8S,9S,10R,11S,13S,14S,17S)-17-(2,2-dihydroxyacetyl)-11-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H30O5
(8S,9S,10R,11R,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O5
(8S,9S,10R,11S,13S,14S,17S)-1,2-dideuterio-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O5